vs

Side-by-side financial comparison of Strawberry Fields REIT, Inc. (STRW) and Zymeworks Inc. (ZYME). Click either name above to swap in a different company.

Strawberry Fields REIT, Inc. is the larger business by last-quarter revenue ($40.1M vs $27.6M, roughly 1.5× Zymeworks Inc.). Strawberry Fields REIT, Inc. runs the higher net margin — 5.0% vs -71.0%, a 76.0% gap on every dollar of revenue. On growth, Zymeworks Inc. posted the faster year-over-year revenue change (72.6% vs 31.5%).

Strawberry Fields REIT, Inc. is a real estate investment trust focused on healthcare-related real estate assets. It owns, operates and manages skilled nursing facilities, senior living communities, and medical office buildings, primarily serving markets across the United States for healthcare providers and elderly care operators.

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital th...

STRW vs ZYME — Head-to-Head

Bigger by revenue
STRW
STRW
1.5× larger
STRW
$40.1M
$27.6M
ZYME
Growing faster (revenue YoY)
ZYME
ZYME
+41.1% gap
ZYME
72.6%
31.5%
STRW
Higher net margin
STRW
STRW
76.0% more per $
STRW
5.0%
-71.0%
ZYME

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
STRW
STRW
ZYME
ZYME
Revenue
$40.1M
$27.6M
Net Profit
$2.0M
$-19.6M
Gross Margin
Operating Margin
52.4%
-80.1%
Net Margin
5.0%
-71.0%
Revenue YoY
31.5%
72.6%
Net Profit YoY
37.6%
34.3%
EPS (diluted)
$0.15
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STRW
STRW
ZYME
ZYME
Q4 25
$40.1M
Q3 25
$39.7M
$27.6M
Q2 25
$37.9M
$48.7M
Q1 25
$37.3M
$27.1M
Q4 24
$30.5M
$31.0M
Q3 24
$29.5M
$16.0M
Q2 24
$29.3M
$19.2M
Q1 24
$27.8M
$10.0M
Net Profit
STRW
STRW
ZYME
ZYME
Q4 25
$2.0M
Q3 25
$2.0M
$-19.6M
Q2 25
$2.0M
$2.3M
Q1 25
$1.6M
$-22.6M
Q4 24
$1.5M
$-23.5M
Q3 24
$944.0K
$-29.9M
Q2 24
$938.0K
$-37.7M
Q1 24
$746.0K
$-31.7M
Operating Margin
STRW
STRW
ZYME
ZYME
Q4 25
52.4%
Q3 25
56.6%
-80.1%
Q2 25
54.5%
-1.4%
Q1 25
54.1%
-94.5%
Q4 24
51.5%
-71.6%
Q3 24
54.4%
-213.8%
Q2 24
52.3%
-222.9%
Q1 24
51.3%
-376.9%
Net Margin
STRW
STRW
ZYME
ZYME
Q4 25
5.0%
Q3 25
5.1%
-71.0%
Q2 25
5.2%
4.8%
Q1 25
4.2%
-83.5%
Q4 24
4.8%
-75.8%
Q3 24
3.2%
-186.6%
Q2 24
3.2%
-195.8%
Q1 24
2.7%
-315.6%
EPS (diluted)
STRW
STRW
ZYME
ZYME
Q4 25
$0.15
Q3 25
$0.16
$-0.26
Q2 25
$0.16
$0.03
Q1 25
$0.13
$-0.30
Q4 24
$0.17
$-0.32
Q3 24
$0.14
$-0.39
Q2 24
$0.14
$-0.49
Q1 24
$0.12
$-0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STRW
STRW
ZYME
ZYME
Cash + ST InvestmentsLiquidity on hand
$31.8M
$64.8M
Total DebtLower is stronger
$794.7M
Stockholders' EquityBook value
$12.1M
$320.1M
Total Assets
$885.2M
$397.3M
Debt / EquityLower = less leverage
65.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STRW
STRW
ZYME
ZYME
Q4 25
$31.8M
Q3 25
$19.8M
$64.8M
Q2 25
$96.3M
$98.3M
Q1 25
$42.3M
$76.2M
Q4 24
$48.4M
$66.1M
Q3 24
$29.3M
$122.4M
Q2 24
$16.1M
$71.0M
Q1 24
$15.1M
$114.8M
Total Debt
STRW
STRW
ZYME
ZYME
Q4 25
$794.7M
Q3 25
$779.4M
Q2 25
$794.1M
Q1 25
$715.5M
Q4 24
$673.9M
Q3 24
$584.5M
Q2 24
$555.0M
Q1 24
$560.4M
Stockholders' Equity
STRW
STRW
ZYME
ZYME
Q4 25
$12.1M
Q3 25
$14.2M
$320.1M
Q2 25
$15.5M
$334.5M
Q1 25
$19.6M
$325.0M
Q4 24
$18.2M
$338.8M
Q3 24
$12.6M
$367.0M
Q2 24
$7.4M
$406.2M
Q1 24
$7.5M
$438.0M
Total Assets
STRW
STRW
ZYME
ZYME
Q4 25
$885.2M
Q3 25
$880.6M
$397.3M
Q2 25
$897.3M
$408.4M
Q1 25
$834.8M
$425.5M
Q4 24
$787.6M
$463.1M
Q3 24
$661.5M
$487.2M
Q2 24
$635.9M
$515.6M
Q1 24
$634.9M
$553.8M
Debt / Equity
STRW
STRW
ZYME
ZYME
Q4 25
65.64×
Q3 25
54.70×
Q2 25
51.26×
Q1 25
36.47×
Q4 24
37.09×
Q3 24
46.34×
Q2 24
74.61×
Q1 24
74.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STRW
STRW
ZYME
ZYME
Operating Cash FlowLast quarter
$90.0M
$-31.4M
Free Cash FlowOCF − Capex
$-31.8M
FCF MarginFCF / Revenue
-115.2%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
44.62×
TTM Free Cash FlowTrailing 4 quarters
$-65.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STRW
STRW
ZYME
ZYME
Q4 25
$90.0M
Q3 25
$20.7M
$-31.4M
Q2 25
$29.8M
$12.1M
Q1 25
$19.0M
$-3.4M
Q4 24
$59.3M
$-41.5M
Q3 24
$11.8M
$-5.9M
Q2 24
$20.6M
$-25.0M
Q1 24
$2.1M
$-37.7M
Free Cash Flow
STRW
STRW
ZYME
ZYME
Q4 25
Q3 25
$-31.8M
Q2 25
$11.6M
Q1 25
$-3.4M
Q4 24
$-41.8M
Q3 24
$-6.8M
Q2 24
$-25.6M
Q1 24
$-37.9M
FCF Margin
STRW
STRW
ZYME
ZYME
Q4 25
Q3 25
-115.2%
Q2 25
23.7%
Q1 25
-12.6%
Q4 24
-134.8%
Q3 24
-42.4%
Q2 24
-133.0%
Q1 24
-377.5%
Capex Intensity
STRW
STRW
ZYME
ZYME
Q4 25
Q3 25
1.5%
Q2 25
1.1%
Q1 25
0.1%
Q4 24
1.0%
Q3 24
5.6%
Q2 24
3.1%
Q1 24
1.8%
Cash Conversion
STRW
STRW
ZYME
ZYME
Q4 25
44.62×
Q3 25
10.26×
Q2 25
15.24×
5.21×
Q1 25
11.97×
Q4 24
40.44×
Q3 24
12.53×
Q2 24
21.93×
Q1 24
2.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons